$18.32 Last:
1.78% Change Percent:
$18.23 Open:
$18.32 Previous Close:
$18.64 High:
$16.83 Low:
850,833 Volume:
03/04/2021 04:57:27 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2021-03-04 | 18.23 | 18.32 | 18.64 | 16.83 | 850,833 |
2021-03-03 | 19.03 | 18 | 19.5 | 18 | 551,696 |
2021-03-02 | 19 | 18.75 | 19.59 | 18.72 | 372,417 |
2021-03-01 | 18.33 | 18.85 | 19.24 | 18.1783 | 474,923 |
2021-02-26 | 18.5 | 17.75 | 19.27 | 17.74 | 654,919 |
2021-02-25 | 19.34 | 18.36 | 21.23 | 18.36 | 1,053,554 |
2021-02-24 | 18.47 | 18.36 | 18.94 | 18 | 690,295 |
2021-02-23 | 18 | 18.06 | 19.83 | 18 | 817,972 |
2021-02-22 | 19.66 | 19 | 19.7 | 18.23 | 838,141 |
2021-02-19 | 19.47 | 19.84 | 21 | 19.4 | 916,232 |
2021-02-18 | 20.18 | 19.37 | 20.38 | 19.3491 | 699,973 |
2021-02-17 | 21.22 | 20.36 | 21.74 | 20 | 885,075 |
2021-02-16 | 24 | 21.28 | 24.23 | 21.28 | 1,196,288 |
2021-02-15 | 22.71 | 23.55 | 23.75 | 22.2501 | 587,554 |
2021-02-12 | 22.71 | 23.55 | 23.75 | 22.2501 | 586,909 |
2021-02-11 | 22.85 | 23.06 | 23.49 | 22.224 | 477,403 |
2021-02-10 | 23.6 | 22.57 | 24.08 | 22.0101 | 760,368 |
2021-02-09 | 24.41 | 23.57 | 24.85 | 23.5 | 528,037 |
2021-02-08 | 21.64 | 24.43 | 24.43 | 21.2 | 1,058,275 |
2021-02-05 | 20.97 | 23.59 | 23.9051 | 20.75 | 1,379,782 |
Cel-Sci Corporation Company Name:
CVM Stock Symbol:
NYSE Market:
News, Short Squeeze, Breakout and More Instantly...
CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the quarter ended December 31, 2020, as well as key clinical and corporate developments. Clinical and Corporate Developments include: In December 2020 , CEL-SCI updated the status of its pivo...
The battle between retail investors of GameStop (NYSE: GME) and its institutional bears reached a pinnacle on Jan. 26 as the stock reached an all-time high of $380 per share. Over the past year, enthusiasm among traders of the legendary r/WallStreetBets subreddit was m...
CEL-SCI Corporation (NYSE American: CVM) , a Phase 3 cancer immunotherapy company, today announced that Geert Kersten, Chief Executive Officer, is scheduled to present at the 2021 H.C. Wainwright BIOCONNECT Virtual Conference, being held on January 11-14, 2021. The presentation ...